Jean Stanley, MLS(ASCP)SBB
Senior Manager, Medical Affairs - Blood Screening
Roche Diagnostics Solutions
Transfusion-Transmitted Malaria: APAC Perspective and New Tools to Detect Infections in Blood Donors
Thursday, 29th August 2024
11:00 am - 12:00 pm (GMT +8)
View other Time Zones
Malaria in humans is usually acquired through a mosquito bite, but it may also be transmitted through transfusion of infected red blood cells.
Transfusion-transmitted malaria is a complication of transfusion that can be potentially fatal.
To mitigate the risk, various strategies have been used, from donor deferral to testing by microscopy, antigen or antibody. Recently, donor screening tests have been developed to test for Plasmodium’s RNA.
Join us in this webinar, where our expert will review the various testing strategies, and the situations where blood donors and blood recipients may benefit from the use of a more sensitive molecular assay for Plasmodium infections.
Who should attend:
- Participants include Blood bank directors, Blood bank medical directors, Blood bank managers, Blood bank technicians, Blood bank scientists and anyone interested in Plasmodium testing in blood donors.
Key reasons to attend:
- Learn about Plasmodium infections in blood donors and the risk of transfusion-transmitted malaria.
- Understand the current testing strategies, and the value of each in preventing transfusion-transmitted malaria.
- Uncover the facts about molecular methods for detecting Plasmodium infections in blood donors, and how they can help secure the blood supply.
Faculty
Speaker |
|
SpeakerJean Stanley, MLS(ASCP)SBBSenior Manager, Medical Affairs - Blood Screening |
Jean Stanley holds a Bachelors of Science in Biological Science, as well as a Masters in Business Administration. She is certified as a Medical Laboratory Scientist, a Specialist in Blood Banking, and as Manager of Quality/Organizational Excellence.
She is a certified Quality Auditor and holds a Six Sigma Black Belt. Jean has more than 40 years of technical and administrative experience in the blood center, hospital transfusion service and diagnostics industry.
She has a specialty in quality management and Lean operating principles. She has authored multiple publications, book chapters and presentations. She is a member of various AABB committees and ISBT working parties.
Jean joined Roche in 2016, and is currently the Senior Manager for Medical Affairs in Blood Screening
Moderator |
Dr. Aseem TiwariDirector & In-charge, Department of Transfusion Medicine |
|
ModeratorDr. Aseem TiwariDirector & In-charge, Department of Transfusion Medicine |
Dr. Aseem Tiwari is trained in Transfusion Medicine at SGPGI, Lucknow. He is currently the Director of the Department of Transfusion Medicine at Medanta Hospital, Gurgaon, India.
He has over 140 publications in national and international journals and is reviewer to several journals, including: Transfusion Medicine/Transfusion and Apheresis Science/Journal of Blood Transfusion/Journal of Blood Disorders and Transfusion/ AJTS/IJHBT/Hematology Reports/Pediatric Hematology and Oncology Journal/GJTM.
His research interests include immunohematology, infectious disease markers (IDM), therapeutic apheresis and cellular therapies.
Live Webinar Date & Time
 |
Date:29th August 2024 at 11:00 am - 12:00 pm (GMT+8) |
 |
|
Transfusion-transmitted dengue: Current perspectives and prevention strategies
Wednesday, 20th November 2024
15:00 - 16:00 (GMT +8)
View other Time Zones
Dengue cases have surged worldwide during the 2023-24 outbreak season, with the WHO reporting close to a historic high of over five million cases and more than 5000 dengue-related deaths in over 80 countries.
Dengue is capable of causing a transfusion-transmitted infection, with several case reports, including a case of severe dengue haemorrhagic fever. The risk of transfusion-transmitted dengue can be managed in different ways, including careful donor screening and deferral, and screening tests specific for dengue. Screening tests may be based on location-specific triggers, such as an outbreak in a non-endemic area, or specific factors in endemic areas. For example, during an autochthonous dengue outbreak in the Lazio region of Italy in August 2023, dengue screening by molecular testing was activated in all organ, tissue, haematopoietic stem cells and blood donors from the designated risk areas.
With dengue infections currently soaring, and even with vector control, personal protection, and most recently a dengue vaccine, the possibility of transfusion transmission exists via asymptomatic donors. It is important to be aware of the possibility, and consider the right management strategy based on local factors.
Join us in this webinar, where our expert will review the various testing strategies, and the situations where blood donors and blood recipients may benefit from the use of a NAT assay for dengue infections.
Who should attend:
- Participants include Blood bank directors, Blood bank medical directors, Blood bank managers, Blood bank technicians, Blood bank scientists and anyone interested in dengue testing in blood donors.
Key reasons to attend:
- Learn about dengue infections in blood donors and the risk of transfusion-transmitted dengue.
- Understand the current testing strategies, and the value of each in preventing transfusion-transmitted dengue.
- Uncover the facts about molecular methods for detecting dengue infections in blood donors, and how they can help secure the blood supply.
Faculty
Moderator |
Associate Professor Pimpun KitpokaMedical Director, Clinical Pathologist |
|
SpeakerAssociate Professor Pimpun KitpokaMedical Director, Clinical Pathologist |
Dr. Kitpoka is currently an associate professor at the faculty of medicine, Ramathibodi hospital, Bangkok, Thailand as a blood bank director. She has been employed as a lecturer in clinical pathology and transfusion medicine for medical students over 30 years. She also directs postgraduate students in MSc, PhD and residency training in clinical pathology, transfusion medicine and hematology. She is a committee member of the Royal Pathology Society of Thailand, Thai Society of Clinical Pathology, National Blood Center of the Thai Red Cross and the President of the Thai Board Training and Examination for residency training in transfusion medicine. Dr. Kitpoka has authored publications specializing in immunohematology, infectious marker screening and clinical practice in transfusion medicine.
Speaker |
Dr. Ilaria PatiHead of the Haemovigilance and Epidemiological Surveillance of Blood Donors Sector, CNS |
|
SpeakerDr. Ilaria PatiHead of the Haemovigilance and Epidemiological Surveillance of Blood Donors Sector, CNS |
Ilaria Pati is a biologist, PhD in functional and applied genomics and proteomics, with a master’s degree in molecular virology. She has many years of experience in infectious diseases and transfusion-transmitted infectious diseases. She is head of the haemovigilance and epidemiological surveillance sector of the National Blood Centre and Scientific director of external quality assessment programs for blood establishment at the Italian National Institute of Health. She is a member of the Epidemic Intelligence Analysts Group of the Italian Ministry of Health and professor at the master’s degree in molecular virology at “Sapienza” University of Rome. She is also author of numerous publications in journals of international impact in the field of infectious diseases, haemovigilance and epidemiological surveillance.
Live Webinar Date & Time
|
Date:20th November 2024 at 15:00 - 16:00 (GMT+8) |
|
|